Remy
Administrator
Oxaloacetate (OA) is a supplement that is created from a natural metabolite of the Krebs cycle. It works by improving the NAD/NADH ratio and by increasing AMPK. This improves the metabolism in general by lowering and stabilizing blood sugar.
At higher doses, OA will reduce glutamate levels in the brain and improve brain function as well.
It also has benefits to the mitochondria. Not only does OA increase the number of mitochondria, it also feeds them and helps them to produce ATP.
There have been a few animal studies done but no human studies as of yet since it is not a patentable product. However, some people are using it in very high doses to treat things like brain cancer that have very low survival rates otherwise.
The downside is again the cost given the doses needed to be effective and the fact that it needs to be taken continuously. Some benefit would be seen at as little as 100 mg/day but I think for the corrective metabolic action we would want to see in MECFS, a larger dose would be required. I have no idea what that dose might be though I sure do wish someone would study it!
Here's a podcast with the developer of BenaGene:
At higher doses, OA will reduce glutamate levels in the brain and improve brain function as well.
It also has benefits to the mitochondria. Not only does OA increase the number of mitochondria, it also feeds them and helps them to produce ATP.
There have been a few animal studies done but no human studies as of yet since it is not a patentable product. However, some people are using it in very high doses to treat things like brain cancer that have very low survival rates otherwise.
The downside is again the cost given the doses needed to be effective and the fact that it needs to be taken continuously. Some benefit would be seen at as little as 100 mg/day but I think for the corrective metabolic action we would want to see in MECFS, a larger dose would be required. I have no idea what that dose might be though I sure do wish someone would study it!
Here's a podcast with the developer of BenaGene: